Adverse drug reactions of imatinib in patients with chronic myeloid leukemia: A single-center surveillance study (vol 6, pg 30, 2015)

被引：0
|
作者：
Francis, J.
Palaniappan, M.
Dubashi, B.
Pradhan, S. C.
Chandrasekaran, A.
机构：
来源：
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS | 2015年 / 6卷 / 02期
关键词：
D O I：
10.4103/0976-500X.155497
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：122 / 122
页数：1
相关论文
共 50 条
  • [21] Prior exposure to imatinib does not impact outcome of allogeneic hematopoietic transplantation for chronic myeloid leukemia patients: a single-center experience in china
    Shen, Kefeng
    Liu, Qifa
    Sun, Jing
    Jiang, Qianli
    Ye, Yanyan
    Huang, Hao
    Meng, Fanyi
    Zhou, Yongjun
    Yang, Mo
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (02): : 2495 - 2505
  • [22] A Retrospective Cohort Study of Upfront Nilotinib in Chronic Myeloid Leukemia: A Single-Center Experience
    Singh, Reema
    Kapoor, Jyotsna
    Ahmed, Rayaz
    Mehta, Pallavi
    Khushoo, Vishvdeep
    Agrawal, Pragya
    Bhurani, Dinesh
    Agrawal, Narendra
    SOUTH ASIAN JOURNAL OF CANCER, 2021, 10 (04) : 246 - 250
  • [23] Cutaneous adverse reactions of imatinib therapy in patients with chronic myeloid leukemia: A six-year follow up
    Dervis, Emine
    Ayer, Mesut
    Akin Belli, Asli
    Barut, Saime Gul
    EUROPEAN JOURNAL OF DERMATOLOGY, 2016, 26 (02) : 133 - 137
  • [24] Cutaneous adverse reactions of imatinib therapy in patients with chronic myeloid leukemia: A six-year follow up
    Emine Dervis
    Mesut Ayer
    Asli Akin Belli
    Saime Gul Barut
    European Journal of Dermatology, 2016, 26 : 133 - 137
  • [25] Comparison of Adverse Drug Reactions Between Patients Treated With Ceftaroline or Ceftriaxone: A Single-Center, Matched Cohort Study
    Jansen, Jeffrey W.
    Linneman, Travis W.
    Tan, Xing
    Moenster, Ryan P.
    OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (07):
  • [26] Efficacy of Imatinib Dose Escalation in Patients With Chronic Myeloid Leukemia in Chronic Phase (vol 115, pg 551, 2009)
    Kantarjian, H. M.
    Larson, R. A.
    Guilhot, F.
    O'Brien, S. G.
    Mone, M.
    Rudoltz, M.
    Krahnke, T.
    Cortes, J.
    Druker, B. J.
    CANCER, 2010, 116 (15) : 3750 - 3750
  • [27] Efficacy of Generic Imatinib After Switching from Original in Treatment of Patients with Chronic Myeloid Leukemia in the Republic of North Macedonia - A Single-Center Experience
    Dukovski, Dushko
    Trajkova, Sanja
    Stojanovska, Simona
    Ridova, Nevenka
    Panovska-Stavridis, Irina
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S232 - S232
  • [28] The Outcome of Antifungal Prophylaxis with Posaconazole in Patients with Acute Myeloid Leukemia: A Single-Center Study
    Ozkocaman, Vildan
    Ozkalemkas, Fahir
    Seyhan, Serdar
    Ener, Beyza
    Ursavas, Ahmet
    Ersal, Tuba
    Kazak, Esra
    Demirdogen, Ezgi
    Mistik, Resit
    Akalin, Halis
    TURKISH JOURNAL OF HEMATOLOGY, 2018, 35 (04) : 277 - 282
  • [29] EVALUATION OF THE EFFECTIVENESS AND TOXICITY OF GLIVEC AND GENERIC IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA. REVIEW IN A SINGLE CENTER
    Vilaseca, Creus Xavier
    Ramila, Herrero Maria Elena
    Piedra, Sanchez Jordi
    Soriano, Gutierrez Laura
    Segura, de laTorre Laura
    Martinez, de Sola Montserrat
    Piernas, Pontanillas Sonia
    Gomez, Nunez Marta
    Soler, Campos
    Juan, Alfonso
    Roig, Martinez Immaculada
    HAEMATOLOGICA, 2020, 105 : 247 - 247
  • [30] Comparable Efficacy and Safety of Generic Imatinib and Branded Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia With a Consideration of Socioeconomic Characteristics: A Retrospective Study From a Single Center (vol 20, pg e304, 2020)
    Dou, Xuelin
    Qin, Yazhen
    Lai, Yueyun
    Shi, Hongxia
    Huang, Xiaojun
    Jiang, Qian
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (01): : E84 - E84
12345